Acute Effects of Furosemide on Hemodynamics and Pulmonary Congestion in Acute Decompensated Heart Failure.
Acute Heart Failure
About this trial
This is an interventional treatment trial for Acute Heart Failure
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years Clinical diagnosis of acute heart failure requiring hospitalization Systolic blood pressure ≥100 mmHg Oxygen saturation <94% or need of oxygen Confirmed pulmonary congestion on x-ray or ReDS Exclusion Criteria: More than 40 mg iv furosemide within the last three hours before randomization, including prehospital administration Ongoing ventricular taky- or brady-arrythmias or supraventricular arrhythmias with HR > 180 or < 40 bpm. Known chronic obstructive lung disease Pacemaker or ICD on the right side Congenital heart malformations or intra-thoracic mass that would affect the right lung anatomy (e.g. dextrocardia, lung carcinoma) Wounds, burns, healing tissue, skin infection or recent skin graft or flap where the sensors should be attached to the skin Height less than 155 cm or higher than 200 cm BMI of less than 18 or more than 38
Sites / Locations
- Amager-Hvidovre HospitalRecruiting
Arms of the Study
Arm 1
Experimental
Furosemide
80 mg of furosemide is administered IV